HOME >> MEDICINE >> NEWS
Women and heart disease: The role of diabetes and hyperglycemia

In a special article in the May 10 issue of The Archives of Internal Medicine, Elizabeth Barrett-Connor, M.D., of the University of California, San Diego, and colleagues explore the role of diabetes among women with cardiovascular disease (CVD).

According to the article, CVD is the primary cause of death in women, and women with type 2 diabetes mellitus are at a greater risk of CVD compared to nondiabetic women. "In the United States, 498,863 women died from CVD in 2001, compared with 266,693 deaths from cancer," the authors write. However, in a large survey of women conducted in 2003, fewer than half of the women surveyed perceived heart disease as their greatest health threat.

In addition to high blood glucose levels (the hallmark of diabetes), there are other risk factors that contribute to a higher risk for CVD among diabetic women, including hypertension, dyslipidemia (an imbalanced lipid and cholesterol profile) and cigarette smoking.

"With the diagnosis of diabetes, the relative risk of CVD increases more in women than in men," write the authors. "For instance, the risk of acute myocardial infarction (MI, or heart attack) is 150 percent greater in diabetic than in nondiabetic women but only 50 percent greater in diabetic than in nondiabetic men, according to the Framingham [a large study] data."

The authors outline several strategies for treating women with diabetes and CVD, including controlling blood glucose levels in order to get the diabetes under control. "The Diabetes Control and Complications Trial, a study conducted in patients with type 1 diabetes, demonstrated a 41 percent reduction (albeit nonsignificant ) in cardiovascular events in those undergoing intensive therapy and better blood glucose control."

Preventing diabetes is another strategy the researchers discuss. "Type 2 diabetes mellitus is preventable, and hyperglycemia [high blood glucose], the universal feature of diabetes, is treatable," they
'"/>

Contact: Brian Dotson
212-305-5587
JAMA and Archives Journals
10-May-2004


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Women less likely to get quality heart attack care
3. Statement on the findings of the Womens Health Study
4. Women should be advised not to drink alcohol in pregnancy
5. Women with thyroid problem have lower risk of breast cancer
6. Women successfully treated to prevent preterm labor at low risk for recurrent episode
7. Womens heart risk underestimated by doctors, resulting in less preventive care than in men
8. Women, drinking to their health
9. Women want annual pap smears
10. Women In Government report on eliminating cervical cancer
11. Women need less morphine after hysterectomies with new treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women and heart disease The role diabetes and hyperglycemia

(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: